IL6ST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.681600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.205600E-01
Normal-vs-Stage2
3.944000E-01
Normal-vs-Stage3
7.970200E-02
Normal-vs-Stage4
9.182600E-01
Stage1-vs-Stage2
4.026000E-01
Stage1-vs-Stage3
9.891800E-02
Stage1-vs-Stage4
8.691400E-01
Stage2-vs-Stage3
2.607400E-01
Stage2-vs-Stage4
3.864400E-01
Stage3-vs-Stage4
3.608300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.748600E-01
Normal-vs-AfricanAmerican
7.131600E-01
Normal-vs-Asian
9.667800E-02
Caucasian-vs-AfricanAmerican
2.741600E-01
Caucasian-vs-Asian
2.128400E-01
AfricanAmerican-vs-Asian
1.762170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.099200E-01
Normal-vs-Female
4.570400E-01
Male-vs-Female
4.588000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.443400E-01
Normal-vs-Age(41-60Yrs)
7.026400E-01
Normal-vs-Age(61-80Yrs)
2.474000E-01
Normal-vs-Age(81-100Yrs)
1.964010E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.909000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.660000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.617600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.810400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.335400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.170300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.052200E-02
Normal-vs-Daily Drinker
3.877200E-03
Normal-vs-Weekly Drinker
2.121600E-01
Normal-vs-Occasional Drinker
2.652000E-01
Normal-vs-Social Drinker
8.666800E-01
Non Drinker-vs-Daily Drinker
1.369000E-01
Non Drinker-vs-Weekly Drinker
7.724800E-01
Non Drinker-vs-Occasional Drinker
5.073600E-01
Non Drinker-vs-Social Drinker
1.739380E-01
Daily Drinker-vs-Weekly Drinker
2.111000E-01
Daily Drinker-vs-Occasional Drinker
9.140100E-02
Daily Drinker-vs-Social Drinker
6.001900E-02
Weekly Drinker-vs-Occasional Drinker
7.921800E-01
Weekly Drinker-vs-Social Drinker
2.601400E-01
Occasional Drinker-vs-Social Drinker
3.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.170600E-01
Normal-vs-Grade 2
2.000400E-01
Normal-vs-Grade 3
1.309770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.707400E-01
Grade 1-vs-Grade 3
9.681400E-01
Grade 1-vs-Grade 4
2.170600E-01
Grade 2-vs-Grade 3
8.011200E-01
Grade 2-vs-Grade 4
2.000400E-01
Grade 3-vs-Grade 4
1.309770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.501400E-01
Normal-vs-NonDiabetic
2.980200E-01
Diabetic-vs-NonDiabetic
8.933600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.236600E-01
Normal-vs-NoPancreatitis
3.298200E-01
Pancreatitis-vs-NoPancreatitis
2.348500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.174600E-01
Normal-vs-N1
4.130400E-01
N0-vs-N1
6.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.766610E-01
Normal-vs-TP53-NonMutant
7.654800E-01
TP53-Mutant-vs-TP53-NonMutant
3.028000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
